Document is current
Any future updates will be listed below
-
Authors
Ferro, Richard https://orcid.org/0009-0009-5813-315X
North, James
Kranenburg, Andy
Pyles, Stephen
Dorenkamp, Clay
Poston, Jason
Schneider, John
Auten, Kacey
Goldberg, Edward
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01550575 at ClinicalTrials.govDocuments that mention this clinical trial
Automated Neural Dosing for Fast-Acting Subperception Therapy: Sustained Spinal Cord Stimulation Outcomes from a Multicenter Study
https://doi.org/10.1007/s40122-025-00758-y
B360 Pain relief outcomes using peripheral nerve/field stimulation (PNFS) combined with spinal cord stimulation: a multicenter european evaluation
https://doi.org/10.1136/rapm-2022-esra.436
ESRA19-0137 Two-year follow-up of a customized field shape using sub-perception spinal cord stimulation in a real-world, observational cohort of chronic pain patients
https://doi.org/10.1136/rapm-2019-esraabs2019.105
ESRA19-0150 Clinical application of an SCS device capable of patient-selective use of multiple available neurostimulative treatment options for chronic pain: real-world outcomes from europe
https://doi.org/10.1136/rapm-2019-esraabs2019.102
-
Funding
Funding for this research was provided by:
Boston Scientific
- License Information
-
More Information
Article History
Received: 5 May 2025
Accepted: 9 June 2025
First Online: 3 July 2025
Declarations
:
: James North received funding from Boston Scientific for data collection for this study, as well as consultancy fees from Boston Scientific. He was also a member of the Boston Scientific Advisory Board. Andy Kranenburg received consultancy fees from Boston Scientific, which were paid directly to his institution. Stephen Pyles has received honoraria for lectures and educational activities, payment for expert testimony, and support for attending meetings and/or travel from Medtronic and Boston Scientific. Clay Dorenkamp received funding from Boston Scientific for data collection for this study; he has also received honoraria from Michigan State University and Mclaren Greater Lansing GME for lectures, as well as from Johnson and Johnson (Synthes) for educational training courses. John Schneider has received honoraria from Boston Scientific for his participation in an expert discussion. Kacey Auten and Edward Goldberg are employees of Boston Scientific. Richard Ferro and Jason Poston state that they have no conflicts of interest to declare.
: The study was conducted in accordance with Good Clinical Practices (ISO14155) guidelines and the Declaration of Helsinki. As the data were fully anonymized, patient consent was not required for this retrospective case review. Ethical approval was obtained for each site from the WCG Institutional Review Board (Supplementary file).
